OGI OGI
Company Profile ↓Company Overview
OGI (OGI) is a publicly traded company listed on with a market capitalization of $130.43M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Revenue has grown at a 48.5% CAGR over the past five years.
Recent Developments
- Sep 2025 Revenue of $259.18M (+62.2% YoY); net profit $-24.76M.
- Trailing 12 Months Year-on-year growth — revenue +62.2%.
- 5-Year Trend Long-term compounding — revenue CAGR 48.5%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 48.49% |
| 1 Year: | 62.15% |
Stock Price Performance
| 1 Year: | -29.41% |
| 6 Months: | -37.96% |
| 3 Months: | -29.92% |
| 1 Month: | +0.63% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)51.82 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 48.5% over 5 years.
CONS
- Trading 53.8% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Revenue | - | 65.60M | 70.79M | 80.06M | 63.54M | 59.79M |
| Cost of Revenue | - | 47.18M | 44.65M | 48.22M | 40.22M | 43.39M |
| Gross Profit | - | 18.42M | 26.15M | 31.84M | 23.32M | 16.41M |
| Operating Expenses | - | 26.00M | 28.25M | 30.65M | 26.73M | 26.20M |
| Operating Income | - | -7.58M | -2.10M | 1.19M | -3.42M | -9.79M |
| EBITDA | - | -2.74M | 2.68M | 6.15M | 1.56M | -4.76M |
| Interest Expense | - | - | - | - | - | - |
| Pretax Income | - | 42.35M | -16.20M | -41.73M | 19.97M | -921.00K |
| Tax Provision | 0 | -106.00K | -9.90M | -3.76M | - | 0 |
| Net Income | - | 42.46M | -6.29M | -37.96M | 19.97M | -921.00K |
| Diluted EPS | -0.20 | 0.32 | -0.05 | - | 0.15 | -0.01 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Aug 2021 | Aug 2022 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 79.16M | 145.81M | 159.84M | 259.18M |
| Cost of Revenue | 107.56M | 114.24M | 112.32M | 168.97M |
| Gross Profit | -28.40M | 31.57M | 47.52M | 90.22M |
| Operating Expenses | 44.44M | 70.32M | 82.28M | 105.52M |
| Operating Income | -72.84M | -38.75M | -34.76M | -15.30M |
| EBITDA | -96.71M | 10.96M | -22.68M | 2.67M |
| Interest Expense | 2.96M | 429.00K | - | - |
| Pretax Income | -130.70M | -14.37M | -45.44M | -38.53M |
| Tax Provision | 0 | -88.00K | 0 | -13.77M |
| Net Income | -130.70M | -14.28M | -45.44M | -24.76M |
| Diluted EPS | -2.04 | -0.18 | -0.48 | -0.19 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Aug 2021 | Aug 2022 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|
| Total Assets | 554.02M | 577.11M | 407.86M | 562.21M |
| Current Assets | 260.62M | 221.62M | 262.22M | 284.90M |
| Cash & Equivalents | 55.37M | 68.52M | 106.75M | 28.20M |
| Inventory | 48.82M | 68.28M | 82.52M | 123.95M |
| Receivables | 20.20M | 43.86M | 32.66M | 63.59M |
| Total Liabilities | 74.21M | 69.05M | 101.87M | 213.08M |
| Current Liabilities | 26.27M | 55.28M | 53.32M | 126.16M |
| Long Term Debt | 230.00K | 155.00K | 25.00K | - |
| Total Debt | 5.95M | 3.36M | 4.46M | 8.75M |
| Total Equity | 479.81M | 508.06M | 305.99M | 349.13M |
| Shares Outstanding | 74.70M | 78.45M | 108.59M | 134.46M |
Cash Flows (Annual)
Figures in USD.
| Metric | Aug 2021 | Aug 2022 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|
| Operating Cash Flow | -28.59M | -36.21M | 3.87M | -7.59M |
| Investing Cash Flow | -115.11M | 44.03M | -30.80M | -81.07M |
| Financing Cash Flow | 174.46M | 5.33M | 107.78M | 39.33M |
| Capital Expenditure | -12.29M | -48.78M | -5.34M | -17.05M |
| Free Cash Flow | -40.88M | -84.99M | -1.47M | -24.64M |
| Net Change in Cash | 30.77M | 13.15M | 80.85M | -49.32M |
Ratios (Annual)
Figures in %.
| Metric | Aug 2021 | Aug 2022 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|
| Gross Margin % | -35.9% | 21.7% | 29.7% | 34.8% |
| Operating Margin % | -92.0% | -26.6% | -21.7% | -5.9% |
| Net Margin % | -165.1% | -9.8% | -28.4% | -9.6% |
| ROE % | -27.2% | -2.8% | -14.9% | -7.1% |
| ROCE % | -13.8% | -7.4% | -9.8% | -3.5% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for OGI
Cannabis company Organigram will report before markets open Aug. 11 - Stock Titan
<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxPTFhaVzRYcG1wMDAyVG9TeTV0RjY1U3JXdHNBVDY4dVgxcXc5NGVaWHJHWkJuTnRVUHNWUTlNMExsQnlLUTYxYS1pUDNySFJLeHVxSDZ5a3hkM3FjalFQaWc3QUxmTjJmU2JBbjFpM2c4MEh1bkZiUjY3LWs0QWZDYm9mMkE2OERreUthV2…
Organigram Global Inc (OGI) Raises 2026 Guidance on Sanity Acquisition - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxQOVNtMjFxVmZvaGcxOHVIYWdUR1dOd01sQlFIS3JrVU12SVlVOVlSR083TVFSUEZ3WEUxM2V6VnNRZnZGQS0tRXlHVEpmUnhKRnk5M3ZwMlZjZWJWc1l6d2RhYjJKQ3h0aGw5ZjFqcUhHVS05NUlreWt1R0FmYWs3dDJ1QldGUG1iajVNTm…
Organigram Global Inc. Revenue Breakdown – TSX:OGI - TradingView
<a href="https://news.google.com/rss/articles/CBMickFVX3lxTE53ZS1lemc3eUI1TW1kVl9POTVNejU1c0pURzFocTUyZVh6b2VPX2d0NXhqdjUzdGNhYmRJVnF1VUNUX1V0M19xVGZObVRHdWhBUE5JWW9oUHFRdXVTWXVsZmhKT2Q3ZTFiUFFZYXNGdGdEZw?oc=5" target="_blank">Organigram Gl…
Organigram stock hits 52-week low on Q2 results (OGI:NASDAQ) - Seeking Alpha
<a href="https://news.google.com/rss/articles/CBMiigFBVV95cUxOZ3lrN2NoQXVqcVZvUUtLMGlYYXlZSE5NV0pIWl9LWk1pc3V0RDJEQXB0MzdVdU9nWVloN1Q1VTVzSUJ4RDd3cU83amN4cGFaZVJHYV9lemQ5T2FKdXVzUmdTaElXTkpMZ1FhZGFaNkhiSndCWHZYUi1qUW9EREhTc3hDRXA2c01fX3c?oc…
Organigram Global (NASDAQ: OGI) sets Q3 2026 earnings call for Aug. 11 - Stock Titan
<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxNcEtYV0JONnVJbzd3T204eHlxNUZxSm5CVURQMjZyME9fM3NqQkNDSDRIWUUySmUxQm8yb3hvMm95UmxhN1h2NklwUHJYSXFUTU56NFZKLTBHa2dfU3lHR0F1aDBjUFd3Q0VxaTZYRmZlRW9abEZBU0VrSzNSYlNFcVQ2S09QcDFKd2ZjS0…
Organigram Reports Second Quarter Fiscal 2026 Results - Business Wire
<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxOMjloU2FEcnVFaS05WnBmUWplajBkWDdTVDVIRzNnelJuenNFU0NhOUZRYnByUU5MdE5KSVluTEtpaTBFUjR0ZjlLY09leHF1RVJ2UGFUbHRDeG43b241RkhfMkNlYlltOXhhYUJXRDk4VUlyTmRDYVpuSEMyRm9CbVhuSUdsQUNGMnRzeX…
OGI — Frequently Asked Questions
What is the current share price of OGI?
As of 2026-08-05 17:25 PDT, OGI trades at $0.97 on NASDAQ/NYSE. Its 52-week range is $0.87 to $2.11.
What is the market capitalisation of OGI?
OGI has a market capitalisation of $130.43M on NASDAQ/NYSE.
What is the P/E ratio of OGI?
OGI trades at a trailing price-to-earnings (P/E) ratio of -5.00. Its price-to-book (P/B) ratio is 0.37.
What is the return on equity (ROE) of OGI?
OGI has a return on equity (ROE) of -7.09%. Its return on capital employed (ROCE) is -3.51%.
Is OGI a good stock to buy?
This page provides a data-driven analysis of OGI, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.